InVivo Therapeutics Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Employees
  • 6


  • Stock Symbol

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.37
  • (As of Thursday Closing)

InVivo Therapeutics General Information


InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Therapeutic Devices
Stock Exchange
Corporate Office
  • One Kendall Square, Building 1400 West
  • Floor 14
  • Cambridge, MA 02139
  • United States
+1 (617) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InVivo Therapeutics Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.37 $0.39 $0.15 - $1.64 $1.15M 3.11M 22.8K -$3.28

InVivo Therapeutics Financials Summary

In Thousands,
TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV (6,488) (5,054) (4,559) 10,345
Revenue 0 0 0 0
EBITDA (9,435) (10,196) (9,526) (8,764)
Net Income (9,327) (10,490) (9,895) (9,074)
Total Assets 9,584 18,822 21,770 21,910
Total Debt 0 949 1,310 1,020
Public Fundamental Data provided by Morningstar, Inc. disclaimer

InVivo Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore InVivo Therapeutics‘s full profile, request access.

Request a free trial

InVivo Therapeutics Comparisons

HQ Location
Total Raised
Post Valuation
InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on
Therapeutic Devices
Cambridge, MA
6 As of 2022


irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nu
00000000000 0000000
Lausanne, Switzerland
00 As of 0000
00 000000 0000


boris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehen
00000000000 0000000
Redwood City, CA
0000 As of 0000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InVivo Therapeutics Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aleva Neurotherapeutics Private Equity-Backed Lausanne, Switzerland 00 0000 00 000000 0000
Nevro Formerly VC-backed Redwood City, CA 0000 00000 000000000 00000
Neuronetics Formerly VC-backed Malvern, PA 000 00000 000000000 00 00000
LivaNova Formerly VC-backed London, United Kingdom 0000 000.00 000000000000
Inspire Medical Systems Formerly VC-backed Golden Valley, MN 0000 00000 000000000 00000
You’re viewing 5 of 7 competitors. Get the full list »

InVivo Therapeutics Patents

InVivo Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170151286-A1 Compositions and methods for preparing an injectable medium for administration into the central nervous system Inactive 01-Dec-2015 000000000
US-20170151416-A1 Methods and systems for delivery of a trail of a therapeutic substance into an anatomical space Inactive 01-Dec-2015 00000000000
US-20170304453-A1 Thiol-ene functionalized hydrogels Inactive 05-Sep-2014 000000000
US-20140271601-A1 Crosslinkable trehalose for the covalent incorporation in hydrogels and methods of use Inactive 13-Mar-2013 000000000 0
JP-2016513653-A Crosslinkable trehalose for covalent incorporation into hydrogels and methods of use Pending 13-Mar-2013 A61K47/34
To view InVivo Therapeutics’s complete patent history, request access »

InVivo Therapeutics Executive Team (14)

Name Title Board Seat Contact Info
Richard Toselli MD Chief Executive Officer & Board Member
Richard Christopher Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Heather Hamel General Counsel, Legal & Chief Legal Officer, Legal
Joseph Vacanti MD Co-Founder
Robert Langer Ph.D Co-Founder & Member of Scientific Advisory Board
You’re viewing 5 of 14 executive team members. Get the full list »

InVivo Therapeutics Board Members (8)

Name Representing Role Since
C. Merrifield Self Chairman & Board Member 000 0000
Christina Morrison Self Board Member 000 0000
Richard Roberts Ph.D Self Board Member 000 0000
Richard Toselli MD InVivo Therapeutics Chief Executive Officer & Board Member 000 0000
Robert Langer Ph.D Self Co-Founder & Member of Scientific Advisory Board 000 0000
You’re viewing 5 of 8 board members. Get the full list »

InVivo Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InVivo Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Design Source 26-Oct-2010 0000000000 Other Commercial Services
To view InVivo Therapeutics’s complete acquisitions history, request access »

InVivo Therapeutics ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.


Covered Companies







Medical Devices




To view InVivo Therapeutics’s complete esg history, request access »

InVivo Therapeutics FAQs

  • When was InVivo Therapeutics founded?

    InVivo Therapeutics was founded in 2005.

  • Who is the founder of InVivo Therapeutics?

    Joseph Vacanti MD, Robert Langer Ph.D, and Francis Reynolds are the founders of InVivo Therapeutics.

  • Who is the CEO of InVivo Therapeutics?

    Richard Toselli MD is the CEO of InVivo Therapeutics.

  • Where is InVivo Therapeutics headquartered?

    InVivo Therapeutics is headquartered in Cambridge, MA.

  • What is the size of InVivo Therapeutics?

    InVivo Therapeutics has 6 total employees.

  • What industry is InVivo Therapeutics in?

    InVivo Therapeutics’s primary industry is Therapeutic Devices.

  • Is InVivo Therapeutics a private or public company?

    InVivo Therapeutics is a Public company.

  • What is InVivo Therapeutics’s stock symbol?

    The ticker symbol for InVivo Therapeutics is NVIVQ.

  • What is the current stock price of InVivo Therapeutics?

    As of 23-May-2024 the stock price of InVivo Therapeutics is $0.37.

  • What is the current market cap of InVivo Therapeutics?

    The current market capitalization of InVivo Therapeutics is $1.15M.

  • Who are InVivo Therapeutics’s competitors?

    Aleva Neurotherapeutics, Nevro, Neuronetics, LivaNova, and Inspire Medical Systems are some of the 7 competitors of InVivo Therapeutics.

  • What is InVivo Therapeutics’s annual earnings per share (EPS)?

    InVivo Therapeutics’s EPS for 12 months was -$3.28.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »